Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.